Group One Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-130,300
| Closed | -$13.3M | – | 8561 |
|
|
2023
Q2 | $13.3M | Sell |
130,300
-1,100
| -0.8% | -$104K | 0.04% | 382 |
|
|
2023
Q1 | $11.9M | Buy |
131,400
+103,500
| +371% | +$6.07M | 0.04% | 390 |
|
|
2022
Q4 | $1.06M | Sell |
27,900
-113,200
| -80% | -$3.9M | ﹤0.01% | 2361 |
|
|
2022
Q3 | $3.55M | Buy |
141,100
+132,200
| +1,485% | +$3.66M | 0.01% | 1446 |
|
|
2022
Q2 | $270K | Sell |
8,900
-33,600
| -79% | -$1M | ﹤0.01% | 4010 |
|
|
2022
Q1 | $1.39M | Buy |
42,500
+23,200
| +120% | +$688K | ﹤0.01% | 2758 |
|
|
2021
Q4 | $509K | Sell |
19,300
-29,000
| -60% | -$2.24M | ﹤0.01% | 4113 |
|
|
2021
Q3 | $4.86M | Sell |
48,300
-5,600
| -10% | -$656K | 0.01% | 1718 |
|
|
2021
Q2 | $7.63M | Buy |
53,900
+34,900
| +184% | +$3.94M | 0.01% | 1307 |
|
|
2021
Q1 | $1.89M | Buy |
19,000
+18,100
| +2,011% | +$2.11M | ﹤0.01% | 2531 |
|
|
2020
Q4 | $111K | Sell |
900
-1,200
| -57% | -$158K | ﹤0.01% | 4491 |
|
|
2020
Q3 | $205K | Sell |
2,100
-9,400
| -82% | -$1.17M | ﹤0.01% | 3626 |
|
|
2020
Q2 | $1.79M | Sell |
11,500
-44,300
| -79% | -$6.73M | 0.01% | 1547 |
|
|
2020
Q1 | $8.05M | Buy |
55,800
+38,300
| +219% | +$7.39M | 0.07% | 328 |
|
|
2019
Q4 | $3.58M | Buy |
17,500
+17,100
| +4,275% | +$3.12M | 0.02% | 883 |
|
|
2019
Q3 | $32K | Buy |
+400
| New | +$33.9K | ﹤0.01% | 4188 |
|
|
2019
Q1 | – | Sell |
-3,200
| Closed | -$180K | – | 5513 |
|
|
2018
Q4 | $180K | Sell |
3,200
-100
| -3% | -$6.11K | ﹤0.01% | 2765 |
|
|
2018
Q3 | $270K | Buy |
+3,300
| New | +$233K | ﹤0.01% | 2790 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$4K | – | 5587 |
|
|
2018
Q1 | $4K | Buy |
+200
| New | +$5.15K | ﹤0.01% | 4566 |
|
Other funds holding RETA
Group One Trading's RETA Position: Q2 2023 in Review
Group One Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2023, closing a stake of 24,376 shares — an estimated $2.31M sold.
Group One Trading first reported a position in RETA in Q1 2018 and held it in 10 quarters. The position peaked at $2.22M in Q1 2023. 214 funds tracked by Wall St. Rank hold RETA as of Q2 2023.
- Group One Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 24,376 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2023, an estimated $2.31M.
- Group One Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2018 and held it in 10 quarters.
- Group One Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.22M in Q1 2023.
- 214 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.